Method for treating cardiovascular diseases
OwnerJohn Brandt, Nagy Farid +2inventors
InventorsJohn Brandt, Nagy Farid, Joseph Jakubowski, Kenneth Winters
Life of this patent
Estimating the term…
Abstract
A method of treating Cardiovascular Diseases comprising administering of a compound of formula (I) or a pharmaceutically acceptable salt, solvate, prodrug, active metabolite, racemate or enantiomer thereof, in conjunction with coronary and non-coronary intervention procedures is disclosed.
Claims14
A method for treating and/or preventing Cardiovascular Diseases and recurrence thereof, in a patient in need thereof, comprising the following steps performed in any order:
- a) administering a compound of formula I
- or a pharmaceutically acceptable salt, solvate, active metabolite, prodrug, racemate or enantiomer thereof;
- and
- b) performing a PCI procedure.
A method for treating and/or preventing Cardiovascular Diseases and recurrence thereof, in a patient in need thereof, comprising the following steps performed in any order:
- a) administering a compound of formula I
- or a pharmaceutically acceptable salt, solvate, active metabolite, prodrug, racemate or enantiomer thereof in combination with aspirin;
- and
- b) performing a PCI procedure.
A method for treating and/or preventing Cardiovascular Diseases and recurrence thereof, in a patient in need thereof, comprising the following steps performed in the order described:
- a) first, administering a compound of formula I
- or a pharmaceutically acceptable salt, solvate, active metabolite, prodrug, racemate or enantiomer thereof, optionally in combination with aspirin;
- b) second, performing a PCI procedure;
- and
- c) third, administering a compound of formula I or a pharmaceutically acceptable salt, solvate, active metabolite, prodrug, racemate or enantiomer thereof, optionally in combination with aspirin.
A device coated or impregnated with a compound of formula I or a pharmaceutically acceptable salt, solvate, prodrug, active metabolite, racemate or enantiomer thereof, for the treatment, prevention or amelioration of Cardiovascular Diseases.
Use of a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt, solvate, prodrug, active metabolite, racemate or enantiomer thereof, in conjunction with a stent for treating and/or preventing recurrence of peripheral vascular disease.
Use of a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt, solvate, prodrug, active metabolite, racemate or enantiomer thereof, in conjunction with a stent for treating and/or preventing recurrence of cerebrovascular disease.
Use of a compound of formula I
- or a pharmaceutically acceptable salt, solvate, prodrug, racemate or enantiomer thereof, in conjunction with a PCI procedure for treating and/or preventing the recurrence of Cardiovascular Diseases comprising administering an effective amount of said compound of formula I optionally in combination with aspirin to a patient in need thereof.
A method of treating and/or preventing Cardiovascular Diseases and/or recurrences thereof, comprising administering a compound of formula I or a pharmaceutically acceptable salt, solvate, prodrug, active metabolite, racemate or enantiomer thereof, in conjunction with a stent impregnated with the compound of formula I, a pharmaceutically acceptable salt, prodrug, active metabolite, racemate or enantiomer thereof, optionally in combination with other cardio-protective agent(s) to a patient in need thereof.
(canceled)
(canceled)
Dependencies are inferred from the claim text.